Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges.

International Clinical Psychopharmacology
Mariela MoshevaDoron Gothelf

Abstract

Multiple studies have shown that pharmacologic treatments for attention-deficit hyperactivity disorder (ADHD), especially stimulants, are generally effective. There is yet a paucity of empirical data, however, for some common clinical conditions overlooked in the ADHD treatment guidelines. Some examples include: in cases of first line treatment failure, it is unclear whether switching from one type of stimulant to another is beneficial. In cases of comorbid ADHD and severe aggressive/disruptive behavior in children, it is unclear whether the best first-line treatment is stimulants or atypical antipsychotics like risperidone. In cases of ADHD with comorbid anxiety disorders, there is no clear evidence regarding optimal treatment. The objectives of this article are to review these issues and propose possible answers for such clinical dilemmas.

References

Jan 13, 1999·Pediatric Clinics of North America·S R Pliszka
Mar 12, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Daniel F ConnorRichard H Melloni
Dec 9, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Stan KutcherSam Tyano
Aug 24, 2004·European Child & Adolescent Psychiatry·Christopher GillbergLena Niklasson
Apr 22, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Howard AbikoffUNKNOWN RUPP ADHD/Anxiety Study Group
Jul 22, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Alceu Gomes Correia FilhoLuis Augusto Rohde
May 25, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Steven R PliszkaUNKNOWN TEXAS CONSENSUS CONFERENCE PANEL ON PHARMACOTHERAPY OF CHILDHOOD ATTENTION DEFICIT HYPERACTIVITY DISORDER
Jun 1, 2006·The Annals of Pharmacotherapy·Aaron P GibsonM Lynn Crismon
Apr 24, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Jorge L ArmenterosMarisabel Davalos
Jul 4, 2007·Primary Care Companion to the Journal of Clinical Psychiatry
Aug 2, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·James M SwansonNora D Volkow
Aug 23, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Daniel GellerCalvin Sumner
Feb 19, 2008·The American Journal of Psychiatry·Jeffrey H NewcornUNKNOWN Atomoxetine/Methylphenidate Comparative Study Group
Jun 27, 2008·Journal of the American Academy of Child and Adolescent Psychiatry·Stephen V FaraoneThomas J Spencer
Oct 29, 2009·JAMA : the Journal of the American Medical Association·Christoph U CorrellAnil K Malhotra
Dec 28, 2010·Trends in Molecular Medicine·Christoph U CorrellAnil K Malhotra
Sep 29, 2011·Journal of Psychopharmacology·Miguel SeixasUlrich Müller
Oct 18, 2011·Pediatrics·UNKNOWN Subcommittee on Attention-Deficit/Hyperactivity DisorderSusanna Visser
Dec 20, 2011·Journal of the American Academy of Child and Adolescent Psychiatry·Timothy E WilensSharon Youcha
Jul 2, 2015·JAMA Psychiatry·Mark OlfsonMichael Schoenbaum
Sep 25, 2015·Journal of Child and Adolescent Psychopharmacology·Catherine G CoughlinMichael H Bloch
Oct 21, 2015·Pediatrics·Richard A EpsteinMelissa McPheeters
Dec 21, 2016·Journal of the American Academy of Child and Adolescent Psychiatry·Gail A EdelsohnJames M Schuster
Jan 4, 2017·Current Problems in Pediatric and Adolescent Health Care·Jeffrey R StrawnLisa L Giles
Jun 30, 2018·Molecular Psychiatry·Arthur CayeLuis Augusto Rohde
Sep 10, 2018·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Barbara FrankeAndreas Reif
Jul 28, 2019·JAMA Network Open·Ryan S SultanMark Olfson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.